(Q44448613)

3 December 2017

title

Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats (English)

1 reference

3 December 2017

R M Craft

1

1 reference

3 December 2017

D M McNiel

series ordinal

2

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

Pharmacology, Biochemistry and Behavior

3 December 2017

published in

1 reference

3 December 2017

volume

75

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

235-245

1 reference

(-)-Pentazocine analgesia in mice: interactions with a sigma receptor system

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900076-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900076-5

7 January 2021

Sex differences in opioid antinociception: kappa and 'mixed action' agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900076-5

7 January 2021

Kappa opioid-induced diuresis in female vs. male rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900076-5

7 January 2021

Receptor-selective antagonism of opioid antinociception in female versus male rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900076-5

7 January 2021

Gender difference in analgesic response to the kappa-opioid pentazocine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900076-5

7 January 2021

Kappa-opioids produce significantly greater analgesia in women than in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900076-5

7 January 2021

The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900076-5

7 January 2021

Butorphanol agonist effects and acute physical dependence in opioid abusers: comparison with morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900076-5

7 January 2021

Antagonism of the discriminative stimulus effects of the kappa-opioid agonist spiradoline

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900076-5

7 January 2021

Antidiuretic effect of morphine in the rat: tolerance and physical dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900076-5

7 January 2021

[3H]U-69593 a highly selective ligand for the opioid kappa receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900076-5

7 January 2021

Evidence that nalorphine, butorphanol and oxilorphan are partial agonists at a κ-opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900076-5

7 January 2021

Tifluadom-induced diuresis in rats. Evidence for an opioid receptor-mediated central action

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900076-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900076-5

7 January 2021

Pentazocine-induced biphasic analgesia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900076-5

7 January 2021

Subjective, psychomotor, and physiological effects of cumulative doses of mixed-action opioids in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900076-5

7 January 2021

Differential involvement of opioid receptors in intrathecal butorphanol-induced analgesia: compared to morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900076-5

7 January 2021

10.1016/S0091-3057(03)00076-5

Identifiers

DOI

1 reference

3 December 2017

1 reference